EUVIMEDEUVIMED entdecken
Crossref

Early response to incretin-based obesity pharmacotherapy

Dimitrios Patoulias, Caterina Conte

Trends in Endocrinology & Metabolism · 2026-11

DOI: 10.1016/j.tem.2026.10.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-11. Verfasst von Dimitrios Patoulias und 1 weiteren Autor:innen. Beteiligte Einrichtung: Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessalonik…. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP-1glucose-dependent insulinotropic polypeptideincretinobesitytreatment response

Autor:innen und Institutionen

  • Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: patoulias@auth.gr.
  • Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, Rome, Italy; Obesity and Obesity-Related Cardiometabolic Complications Research Unit, IRCCS MultiMedica, Milan, Italy.

Zitieren

APA

Patoulias, D., & Conte, C. (2026). Early response to incretin-based obesity pharmacotherapy. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2026.10.011

Vancouver

Patoulias D, Conte C. Early response to incretin-based obesity pharmacotherapy. Trends in Endocrinology & Metabolism. 2026. doi:10.1016/j.tem.2026.10.011

BibTeX
@article{Patoulias2026,
  author = {Patoulias, Dimitrios and Conte, Caterina},
  title = {Early response to incretin-based obesity pharmacotherapy},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1016/j.tem.2026.10.011}
}
Kostenlos starten →